Understanding the 'epidemic of heart failure': a systematic review of trends in determinants of heart failure.
about
Heart failure in the Middle EastEffects of fish oil supplementation on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trials.Development of a heart failure filter for Medline: an objective approach using evidence-based clinical practice guidelines as an alternative to hand searchingNuclear medicine in the management of patients with heart failure: guidance from an expert panel of the International Atomic Energy Agency (IAEA)Gaps in Medical and Device Therapy for Patients with Left Ventricular Systolic Dysfunction: The EchoGap Study.A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010.Age-related changes in rat myocardium involve altered capacities of glycosaminoglycans to potentiate growth factor functions and heparan sulfate-altered sulfationInotropic agents use in patients hospitalized with acute decompensated heart failure: a retrospective analysis from a 22-year registry in a Middle-Eastern Country (1991-2013).Impairment of activities of daily living and incident heart failure in community-dwelling older adults.Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007.The effectiveness of chronic care management for heart failure: meta-regression analyses to explain the heterogeneity in outcomes.Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β.Behind the smile: qualitative study of caregivers' anguish and management responses while caring for someone living with heart failure.Phase 4 Studies in Heart Failure - What is Done and What is Needed?Metabolic manipulation in dilated cardiomyopathy: Assessing the role of trimetazidine.Profiles of self-care management versus consulting behaviors in adults with heart failure.Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.Frequency and significance of unrecognized chronic obstructive pulmonary disease in elderly patients with stable heart failure.Clinical Presentation, Predictors, and Outcomes Among Mineralocorticoid Receptor Antagonist (MRA)-Eligible Acute Heart Failure Patients in the Heart Function Assessment Registry Trial in Saudi Arabia (HEARTS).Long-Term Mortality Rates in Acute De Novo Versus Acute-on-Chronic Heart Failure: From the Heart Function Assessment Registry Trial in Saudi Arabia.Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?Prevalence and outcome of Middle-eastern Arab and South Asian patients hospitalized with heart failure: insight from a 20-year registry in a Middle-eastern country (1991-2010).[Heart failure: expressions of personal knowledge about the disease].Plasma levels of free fatty acid differ in patients with left ventricular preserved, mid-range, and reduced ejection fraction.Serelaxin, recombinant human relaxin-2, for heart failure patients: A systematic review and meta-analysis.Global Public Health Burden of Heart FailureTo die with or from heart failure: a difference that counts
P2860
Q26865181-E1E6EFBB-699C-411D-A140-CADAF5141E1CQ31096498-68AFF49C-3E19-49BF-BE5C-D0CE6DF3258DQ33805599-99A0CA35-8E86-47BE-83C6-10B065C5F088Q33824869-BB097B6D-0653-4D26-8C7C-362C54FCE6D2Q34384769-6EDE19D5-2CCB-4224-A5C3-700DE9623560Q35672064-04340271-281A-4205-A50C-4C9B8EA1F1BDQ35879491-6EFCD0B7-3921-4D78-86D5-06FBF4D4AC25Q35927894-6971AD86-7E1A-4E6E-82C8-54B73BE91F24Q35986991-F177F3E4-DACA-4398-B1B9-83BCD6EDFEA3Q36315180-3D3692F1-6CF1-4809-A13A-A9290E921B6EQ36442743-835F9B65-A90C-49FC-B2F3-977847D7157AQ37924999-B6D4C7A2-0261-4664-9C41-0AF802AF0205Q38653501-A8A8CF40-3EF9-4593-B154-0DAC18A66B3FQ38859866-17D0ABC0-2672-4322-9058-D8837AA45D3FQ42837504-0F60AD4D-3924-4D89-8FFC-88279129FBFEQ43461485-92363E7A-D65E-451D-9066-0F2CEAB6CF24Q43533701-1BF565A0-02B6-404B-BE81-9AB09275C18EQ44099056-CA2704B2-7B8E-4C13-8802-0AA8D684420AQ46224521-59CEAED8-E3C4-4387-AB5E-4E86ACFB6573Q46631980-BFE63C7B-6105-4AC9-AEF6-B4E566888853Q49106557-9F336EBA-FDD5-442A-89A9-CF2DD913869FQ51363641-EAEDF959-0FF4-4F7C-8DFB-161913683A38Q54483473-EC8910D0-E32A-42B2-8BB1-43C3B1C3CB80Q55008921-7900F29A-8AB3-4BA5-81A0-05443D2D014CQ55433994-32E47014-33B7-46F1-A233-D4704455B094Q57095663-7D5E7858-4B83-4192-9A00-BAF3AFBF8BCEQ57418004-2D650AB1-3705-400A-9C3E-1635D1940CEF
P2860
Understanding the 'epidemic of heart failure': a systematic review of trends in determinants of heart failure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Understanding the 'epidemic of ...... determinants of heart failure.
@en
Understanding the 'epidemic of ...... determinants of heart failure.
@nl
type
label
Understanding the 'epidemic of ...... determinants of heart failure.
@en
Understanding the 'epidemic of ...... determinants of heart failure.
@nl
prefLabel
Understanding the 'epidemic of ...... determinants of heart failure.
@en
Understanding the 'epidemic of ...... determinants of heart failure.
@nl
P2093
P2860
P356
P1476
Understanding the 'epidemic of ...... determinants of heart failure.
@en
P2093
Annette J Dobson
Farid Najafi
Konrad Jamrozik
P2860
P304
P356
10.1093/EURJHF/HFP029
P577
2009-02-27T00:00:00Z